Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection

Clinical and Experimental Rheumatology

Volumn 28, Issue 6, 2010, Pages 842-848

  Vazquez Del Mercado M ^a,c   Sanchez Orozco L V ^b   Pauley, B A ^d   Chan, J Y F ^e   Chan, E K L ^d   Panduro, A ^c   Maldonado Gonzalez M ^c   Jimenez Luevanos M A ^g   Martin Marquez B T ^a   Palafox Sanchez C A ^a   Davalos Rodriguez I P ^b   Salazar Paramo M ^b   Gonzalez Lopez L ^h   Gamez Nava J I ⁱ   Satoh, M ^e,f  

^a Edificio P   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^d Department of Oral Biology ^*  (United States)

^e Division of Rheumatology and Clinical Immunology   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g Hospital Regional Dr Valentin Gomez Farias   (Mexico)

^h INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

ⁱ HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Argonaute2; Autoantibodies; Hepatitis B; Hepatitis C; MicroRNA; Viral hepatitis

Indexed keywords

ANTINUCLEAR ANTIBODY; ARGONAUTE 2 PROTEIN; ARGONAUTE 2 PROTEIN ANTIBODY; AUTOANTIBODY; HEPATITIS C ANTIBODY; INTERFERON; KU ANTIBODY; LA ANTIBODY; PROTEIN ANTIBODY; RNA POLYMERASE II ANTIBODY; RO ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN ANTIBOY; UNCLASSIFIED DRUG; EIF2C2 PROTEIN, HUMAN; HEPATITIS B SURFACE ANTIGEN; INITIATION FACTOR 2; MICRORNA; TOLL LIKE RECEPTOR;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISPANIC; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC DISEASE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ANTIBODY SPECIFICITY; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CHILD; EUKARYOTIC INITIATION FACTOR-2; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOPRECIPITATION; INTERFERON TYPE I; MALE; MICRORNAS; MIDDLE AGED; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 79952637846     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. CHAKRAVARTY EF: Viral infection and reactivation in autoimmune disease. Arthritis Rheum. 2008; 58: 2949-57.
2. CACOUB P, SAADOUN D, BOURLIERE M et al.: Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 2005; 43: 764-70.
3. HAN SH: Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8: 403-18.
4. CACOUB P, POYNARD T, GHILLANI P et al:. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204-12.
5. CACOUB P, RENOU C, ROSENTHAL E et al:. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Médecine Interne et Maladies Infectieuses sur le Virus de l'Hépatite C. Medicine (Baltimore) 2000; 79: 47-56.
6. ANTONELLI A, FERRI C, GALEAZZl M et al:. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 2008; 26 (Suppl. 48): S39-47.
7. DELLA ROSSA A, BALDINI C, TAVONI A, BOMBARDIERI S: How HCV has changed the approach to mixed cryoglobulinemia. Clin Exp Rheumatol 2009; 27 (Suppl. 52): S115-23.
8. MCMURRAY RW, ELBOURNE K: Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-701.
9. RONNBLOM L, ELORANTA ML, ALM G V: The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 408-20.
10. BACCALA R, HOEBE K, KONO DH, BEUTLER B, THEOFILOPOULOS AN: TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007; 13: 543-51.
11. MURATORI P, MURATORI L, STROFFOLINI T et al:. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 2003; 131: 118-21.
12. SAADOUN D, LANDAU DA, CALABRESE LH, CACOUB PP: Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford). 2007; 46: 1234-42.
13. Gatselis NK, Georgiadou SP, Koukoulis GK et al.: Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C. Aliment Pharmacol Ther. 2006; 24: 1563-73. (Pubitemid 44915204)
14. BUSKILA D, SHNAIDER A, NEUMANN L et al:. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum. 1998; 28: 107-13.
15. VERBAAN H, CARLSON J, ERIKSSON S et al.: Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245: 127-32.
16. TZANG BS, CHEN TY, HSU TC, LlU YC, TSAY GJ: Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection. Ann Rheum Dis. 1999; 58: 630-4.
17. D'AMICO E, PALAZZI C, CACCIATORE P et al.: Anti-ENA antibodies in patients with chronic hepatitis C virus infection. Dig Dis Sei 2002; 47: 755-9.
18. OMAGARI K, OHBA K, KADOKAWA Y et al.: Anti-extractable nuclear antigens (ENA) antibodies in patients with chronic hepatitis C before and after treatment with interferon. Autoimmunity. 2003; 36: 269-73.
19. KESSENBROCK K, FRITZLER MJ, GROVES M et al:. Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection. J Mol Med. 2007; 85: 953-9.
20. SANCHEZ LV, MALDONADO M, BASTIDASRAMÍREZ BE, NORDER H, PANDURO A: Genotypes and S-gene variability of Mexican hepatitis B virus strains. J Med Virol. 2002; 68: 24-32.
21. RIVAS-ESTILLA MA, SÁNCHEZ OROZCO VL, MATSUI O et al:. Identification of hepatitis C virus (HCV) genotypes in infected patients from the west of Mexico. Hepatol Res 1998; 12: 121-30.
22. VIVAS-ARCEO C, BENAVlDES SA, DE JESUS TRUJILLO J, PANDURO A, RIVAS-ESTILLA AM: Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico. Hepatol Res. 2003; 25: 115-23.
23. Satoh M, Langdon JJ, Hamilton KJ et al.: Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J Clin Invest 1996; 97: 2619-26. (Pubitemid 26187350)
24. REEVES WH, NARAIN S, SATOH M: Autoantibodies in systemic lupus erythematosus. In: KOOPMAN WJ, MORELAND LW, (Eds.) Arthritis and Allied Conditions. A Textbook of Rheumatology, 15th ed. Philadelphia, US: Lippincott Williams and Wilkins, 2005, pp. 1497-521.
25. YAMASAKI Y, NARAIN S, HERNANDEZ L et al.: Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases. Arthritis Res Ther. 2006; 8: R111-20.
26. ANDRADE LE, CHAN EK, RASKA I, PEEBLES CL, ROOS G, TAN EM: Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med. 1991; 173: 1407-19.
27. GOTO N, SUGIURA K, OGAWA Y et al.: Antip80 coilin autoantibodies react with a conserved epitope and are associated with antiDFS70/LEDGF autoantibodies. J Autoimmun 2006; 26: 42-51.
28. OMAGARI K, MATSUO I, OHBA K et al.: Synchronised disappearance of serum HCVRNA, anti-U1 RNP, anti-La/SS-B, and antiScl-70 in a patient with chronic hepatitis. Hepatol Res 2001; 19: 263-9.
29. Satoh M, Chan EKL, Sobel ES et al.: Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 2007; 3: 721-38. (Pubitemid 47455122)
30. TREADWELL EL, ALSPAUGH MA, SHARPGC: Characterization of a new antigen-antibody system(Su) in patients with systemic lupus erythematosus. Arthritis Rheum 1984; 27: 1263-71.
31. SATOH M, LANGDON JJ, CHOU CH et al.: Characterization of the Su antigen, a macromolecular complex of 100/102 and 200 kDa proteins recognised by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 1994; 73: 132-41.
32. JAKYMlW A, LIAN S, EYSTATHIOY T et al.: Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 2005; 7: 1267-74.
33. JAKYMIW A, IKEDA K, FRITZLER MJ, REEVES WH, SATOH M, CHAN EK: Autoimmune targeting of key components of RNA interference. Arthritis Res Ther 2006; 8: R87.
34. Nacionales DC, Kelly-Scumpia KM, Lee PY et al.: Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 2007; 56: 3770-83. (Pubitemid 350100710)
35. LEE PY, KUMAGAI Y, LI Y et al.: TLR7-dependent and Fc{gamma}R-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008; 205: 2995-3006.
36. JOPLING CL: Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans. 2008; 36: 1220-3.
37. MURAKAMI Y, ALY HH, TAJIMA A, INOUE I, SHIMOTOHNO K: Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009; 50: 453-60.
38. JOPLlNG CL, YI M, LANCASTER AM, LEMON SM, SARNOW P: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-81.
39. Henke JI, Goergen D, Zheng J et al:.microRNA- 122 stimulates translation of hepatitis C virus RNA. EMBO J 2008; 27: 3300-10.
40. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W: Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009; 15: 31-3.
41. PEDERSEN IM, CHENG G, WIELAND S et al.: Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-22.
42. ZENG Y, SANKALA H, ZHANG X, GRAVES PR: Phosphorylation of Argonaute 2 at serine387 facilitates its localization to processing bodies. Biochem J. 2008; 413: 429-36.
43. ZHANG YL, GUO YJ, BIN L, SUN SH: Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7. J Hepatol 2009; 51: 29-38.
44. KELLY KM, ZHUANG H, NACIONALES DC et al:. "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/ RNP and Ro 60. Arthritis Rheum 2006; 54: 1557-67.
45. SIOUD M: Innate sensing of self and nonself RNAs by Toll-like receptors. Trends Mol Med 2006; 12: 167-76.
46. Gantier MP, Tong S, Behlke MA et al.: TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J Immunol 2008; 180: 2117-24.
47. JI J, GLASER A, WERNLI M, BERKE JM, MORADPOUR D, ERB P: Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Gen Virol. 2008; 89: 2761-6.
48. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH: Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 1994; 179: 1243-52. (Pubitemid 24091783)